Cholesterol Metabolism in Cancer and Cell Death
Antioxidants & Redox Signaling · 2023-07 · 39 (1-3) · 102-140
DOI: 10.1089/ars.2023.0340 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 17.07.2023. Verfasst von Fangquan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 308 Literaturangaben.
Abstract (Originalsprache)
Significance: Cholesterol is a type of lipid that plays a crucial role in building and maintaining cell membranes, producing certain hormones, and aiding in digestion. The two main types of cholesterol are low-density lipoprotein and high-density lipoprotein, and maintaining a healthy balance between them is essential for cellular function and organism health. Recent Advances: Cholesterol metabolism is a complex and dynamic process that involves biosynthesis, uptake, efflux, transport, and esterification. Disruptions in cholesterol metabolism are implicated in all stages of cancer, contributing to drug resistance, immune evasion, and autophagy dysfunction. These disruptions have also been linked to various types of regulated cell death, such as apoptosis, anoikis, lysosome-dependent cell death, pyroptosis, NETosis, necroptosis, entosis, ferroptosis, alkaliptosis, immunogenic cell death, and paraptosis. Critical Issues: Understanding the complex interplay between cholesterol metabolism and cell death and their impact on cancer development and progression is still a significant challenge. In addition, there is currently a lack of reliable biomarkers that can accurately reflect cholesterol metabolism dysregulation in cancer. Future Directions: To develop more specific and effective cholesterol metabolism-targeted therapies, a better understanding of the mechanisms by which cholesterol metabolism dysregulation contributes to cell death and cancer progression is needed. In addition, improving the accuracy and reliability of biomarkers will be crucial for monitoring and diagnosing cholesterol-related cancer subtypes and evaluating the effectiveness of cholesterol metabolism-targeted therapies. These efforts will require ongoing research and collaboration among multidisciplinary teams of scientists and clinicians. Antioxid. Redox Signal. 39, 102–140.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Rui Kang
Zitieren
APA
Chen, F., Lu, Y., Lin, J., Kang, R., & Liu, J. (2023). Cholesterol Metabolism in Cancer and Cell Death. Antioxidants & Redox Signaling, 39(1-3), 102-140. https://doi.org/10.1089/ars.2023.0340
Vancouver
Chen F, Lu Y, Lin J, Kang R, Liu J. Cholesterol Metabolism in Cancer and Cell Death. Antioxidants & Redox Signaling. 2023;39(1-3):102-140. doi:10.1089/ars.2023.0340
BibTeX
@article{Chen2023,
author = {Chen, Fangquan and Lu, Yanjiao and Lin, Junhao and Kang, Rui and Liu, Jiao},
title = {Cholesterol Metabolism in Cancer and Cell Death},
journal = {Antioxidants & Redox Signaling},
year = {2023},
volume = {39},
number = {1-3},
pages = {102--140},
doi = {10.1089/ars.2023.0340}
}
EUVIMED